Related Experiment Video
Updated: Dec 21, 2025

Preparation and Evaluation of 99mTc-labeled Tridentate Chelates for Pre-targeting Using Bioorthogonal Chemistry
Published on: February 4, 2017
007 (x2)-3-3: 14-3-3 Targeted Compounds as Double Agents
Mary Gannon1, Talene A Yacoubian1
1Center for Neurodegeneration and Experimental Therapeutics, Department of Neurology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Researchers found a compound that can selectively control protein-protein interactions (PPIs) involving 14-3-3 proteins. This discovery opens doors for designing new drugs to regulate these critical cellular interactions.
Area of Science:
- Biochemistry
- Molecular Biology
- Cellular Signaling
Background:
- 14-3-3 proteins are crucial regulators of cellular functions.
- They mediate their functions through interactions with a wide range of client proteins.
- Dysregulation of 14-3-3 protein interactions is implicated in various diseases.
Purpose of the Study:
- To investigate the potential of small molecules to modulate 14-3-3 protein-protein interactions (PPIs).
- To explore the selective stabilization or disruption of specific 14-3-3 client protein interactions.
Main Methods:
- Utilized a semisynthetic compound designed to interact with 14-3-3 proteins.
- Assessed the compound's effect on specific 14-3-3 PPIs in biochemical and cellular assays.
Main Results:
- Demonstrated that the semisynthetic compound could selectively stabilize or disrupt distinct 14-3-3 PPIs.
- The effect of the compound was dependent on the specific binding partner (client protein).
Conclusions:
- A novel approach to pharmacologically targeting 14-3-3 PPIs has been identified.
- This finding supports the development of 14-3-3-specific modulators for therapeutic interventions.
- Future research can focus on designing tailored compounds to regulate critical 14-3-3-mediated pathways.
More Related Videos
Related Concept Videos
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Chemical Agents for Microbial Control
Drug-Receptor Bonds
In...

